📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms. (2020)

First Author: Baumeister J
Attributed to:  Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-019-0629-z

PubMed Identifier: 31728053

Publication URI: http://europepmc.org/abstract/MED/31728053

Type: Journal Article/Review

Volume: 34

Parent Publication: Leukemia

Issue: 4

ISSN: 0887-6924